Nikko Asset Management Americas’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-355,836
| Closed | -$4.36M | – | 209 |
|
2022
Q3 | $4.36M | Sell |
355,836
-392,717
| -52% | -$4.81M | 0.06% | 117 |
|
2022
Q2 | $8.61M | Sell |
748,553
-283,560
| -27% | -$3.26M | 0.11% | 97 |
|
2022
Q1 | $19.6M | Sell |
1,032,113
-1,643,122
| -61% | -$31.3M | 0.14% | 84 |
|
2021
Q4 | $71.6M | Sell |
2,675,235
-1,587,337
| -37% | -$42.5M | 0.38% | 58 |
|
2021
Q3 | $176M | Sell |
4,262,572
-607,124
| -12% | -$25.1M | 0.76% | 36 |
|
2021
Q2 | $286M | Buy |
4,869,696
+612,140
| +14% | +$35.9M | 1.12% | 29 |
|
2021
Q1 | $179M | Sell |
4,257,556
-130,587
| -3% | -$5.48M | 0.88% | 36 |
|
2020
Q4 | $308M | Sell |
4,388,143
-685,965
| -14% | -$48.1M | 1.75% | 16 |
|
2020
Q3 | $142M | Buy |
5,074,108
+81,053
| +2% | +$2.26M | 1.26% | 28 |
|
2020
Q2 | $146M | Sell |
4,993,055
-114,622
| -2% | -$3.35M | 1.91% | 14 |
|
2020
Q1 | $101M | Buy |
5,107,677
+159,450
| +3% | +$3.16M | 1.88% | 17 |
|
2019
Q4 | $147M | Sell |
4,948,227
-10,366
| -0.2% | -$307K | 2.31% | 11 |
|
2019
Q3 | $113M | Buy |
4,958,593
+1,846,893
| +59% | +$42M | 2% | 14 |
|
2019
Q2 | $77M | Buy |
3,111,700
+2,370,395
| +320% | +$58.6M | 1.51% | 21 |
|
2019
Q1 | $18.1M | Buy |
741,305
+739,079
| +33,202% | +$18.1M | 0.48% | 46 |
|
2018
Q4 | $51K | Buy |
2,226
+208
| +10% | +$4.77K | ﹤0.01% | 131 |
|
2018
Q3 | $64K | Buy |
+2,018
| New | +$64K | ﹤0.01% | 129 |
|